Recruiting Dravet Syndrome Studies in Orange
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole hydrochloride (EPX-100) as adjunctive therapy in children a...
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
The purpose of the study is to evaluate the efficacy, safety, and tolerability of zorevunersen in Patients with Dravet syndrome....
About Dravet Syndrome Clinical Trials in Orange
Dravet syndrome is a rare, severe form of epilepsy that begins in the first year of life with prolonged seizures often triggered by fever. It is usually caused by mutations in the SCN1A gene. Treatment includes specific antiseizure medications, avoiding certain drugs that can worsen seizures, and investigational gene therapies.
There are currently 2 dravet syndrome clinical trials recruiting participants in Orange, CALIFORNIA. These studies are seeking a combined 300 participants. Research is being sponsored by Epygenix, Stoke Therapeutics, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Dravet Syndrome Clinical Trials in Orange — FAQ
Are there dravet syndrome clinical trials in Orange?
Yes, there are 2 dravet syndrome clinical trials currently recruiting in Orange, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Orange?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Orange research site will contact you about next steps.
Are clinical trials in Orange free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Orange studies also compensate for your time and travel.
What dravet syndrome treatments are being tested?
The 2 active trials in Orange are testing new therapies including novel drugs, biologics, and treatment approaches for dravet syndrome.
Data updated March 2, 2026 from ClinicalTrials.gov